2024 ESC Guidelines for the management of elevated blood pressure and hypertensionJohn W. McEvoy, Sharon Macdonald, Vera Regitz‐Zagrosek et al.|European Heart Journal|2024Cited by 1.9k
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Kausik K. Ray, Frederick J. Raal et al.|European Heart Journal|2023Cited by 329
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemiaRoberto Ferrari, Alberico L. Catapano, Carlos Aguíar et al.|European Heart Journal Supplements|2016Cited by 101
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapyCarlos Aguíar, Roberto Ferrari, Riccardo C. Bonadonna et al.|Atherosclerosis Supplements|2015Cited by 84
Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysisAkhmetzhan Galimzhanov, Mamas Mamas, Sedralmontaha Istanbuly et al.|European Journal of Preventive Cardiology|2023Cited by 46